Loeb Partners Corp lifted its position in shares of Metlife Inc (NYSE:MET) by 50.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 49,200 shares of the financial services provider’s stock after purchasing an additional 16,400 shares during the period. Loeb Partners Corp’s holdings in Metlife were worth $2,487,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. PGGM Investments increased its position in shares of Metlife by 2.3% during the third quarter. PGGM Investments now owns 576,944 shares of the financial services provider’s stock worth $29,972,000 after purchasing an additional 12,978 shares in the last quarter. Rockefeller Financial Services Inc. increased its position in shares of Metlife by 189.7% during the third quarter. Rockefeller Financial Services Inc. now owns 37,153 shares of the financial services provider’s stock worth $1,930,000 after purchasing an additional 24,330 shares in the last quarter. Intl Fcstone Inc. acquired a new stake in shares of Metlife during the second quarter worth about $383,000. QUANTRES ASSET MANAGEMENT Ltd acquired a new stake in shares of Metlife during the fourth quarter worth about $1,279,000. Finally, CHURCHILL MANAGEMENT Corp increased its position in shares of Metlife by 35.8% during the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 28,309 shares of the financial services provider’s stock worth $1,431,000 after purchasing an additional 7,470 shares in the last quarter. Institutional investors and hedge funds own 76.55% of the company’s stock.
Shares of Metlife Inc (MET) traded up $1.47 during trading hours on Wednesday, hitting $46.67. The stock had a trading volume of 7,666,818 shares, compared to its average volume of 8,272,055. The stock has a market cap of $48,780.00, a price-to-earnings ratio of 10.75, a price-to-earnings-growth ratio of 1.00 and a beta of 1.31. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.16 and a quick ratio of 0.16. Metlife Inc has a fifty-two week low of $43.38 and a fifty-two week high of $55.91.
Metlife (NYSE:MET) last announced its quarterly earnings results on Tuesday, February 13th. The financial services provider reported $0.64 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.05 by ($0.41). Metlife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The firm had revenue of $15.79 billion for the quarter, compared to analysts’ expectations of $15.89 billion. During the same period last year, the firm earned $1.28 EPS. sell-side analysts expect that Metlife Inc will post 4.42 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Monday, February 5th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, February 2nd. This represents a $1.60 annualized dividend and a dividend yield of 3.43%. Metlife’s dividend payout ratio is currently 36.87%.
MET has been the topic of a number of research reports. Deutsche Bank initiated coverage on Metlife in a report on Tuesday, January 2nd. They set a “hold” rating and a $55.00 price target on the stock. Zacks Investment Research raised Metlife from a “hold” rating to a “buy” rating and set a $60.00 price target on the stock in a report on Thursday, November 9th. Wells Fargo & Co lowered their price target on Metlife from $61.00 to $60.00 and set a “buy” rating on the stock in a report on Tuesday, January 30th. ValuEngine lowered Metlife from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 9th. Finally, Sandler O’Neill lowered Metlife from a “buy” rating to a “hold” rating in a report on Friday, November 10th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $57.77.
TRADEMARK VIOLATION NOTICE: “Loeb Partners Corp Has $2.49 Million Holdings in Metlife Inc (MET)” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/14/loeb-partners-corp-has-2-49-million-stake-in-metlife-inc-met.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.